Training Centre

Memorial Sloan-Kettering Cancer Center (MSK), New York/USA
Programme Director:
Hedvig Hricak, MD, PhD

Evaluation Committee

Heiko Schöder, MD, MBA
Hedvig Hricak, MD, PhD


Heiko Schöder, MD, MBA
Lisa Bodei, MD, PhD

Application open

Applicants are asked to send the below-listed documents in ONE single pdf file to the ESOR Office (

  1. A current CV – Please use this template: CV ESOR curriculum vitae template (DOC)
  2. Letter of motivation including previous experience in the field
  3. Letter(s) of recommendation (by the head of department of the current hospital/university)
  4. English language certificate (if available)
  5. Copy of certificate of obtained medical degree
  6. Confirmation of radiology resident status – Please use this template.
  7. Certificate of Covid 19-vaccinations (Please click here to see which Covid-19 vaccinations are accepted in the USA. For frequently asked questions on Covid-19 vaccinations and testing for international travel, please click here.)
  8. List of references to be contacted if necessary
  9. Certificate of active ESR Membership
  10. Copy of passport and medical insurance
  11. List of five most important/relevant publications in international peer reviewed journals (if available)

PLEASE NOTE: Once a candidate is selected and based upon her/his CV, additional documents will be requested by the training center.

Education in partnership with

Memorial Sloan Kettering Cancer Center=

One-Year Research Fellowship in Theranostics


The need to mobilise resources available for sub-specialisation outside Europe and to benefit from worldwide renowned academic institutions led the European School of Radiology (ESOR) and the Memorial Sloan-Kettering Cancer Center (MSK) to take the initiative in jointly offering a molecular imaging/nuclear medicine programme in theranostics hosted in the Molecular Imaging & Therapy Service of the Department of Radiology at MSK.

The overall aim of this programme is to promote clinical research studies in theranostics and advance clinical care for cancer patient outcomes worldwide.

The exchange programme is organised through ESOR and will expose trainees to all aspects of nuclear medicine under the supervision of assigned mentors at MSK in New York, US.

Number of available places

For 2023-2024 one fellowship will be available from autumn 2023 onwards. The exact starting date will be determined in accordance with the training center.


  1. This programme applies to European radiology or nuclear medicine residents in year 4 and 5 of their training.
  2. The candidate should have an interest in theranostics/molecular imaging.
  3. He/She should have excellent knowledge of nuclear medicine.
  4. He/She should also have an interest and basic skills in clinical research, medical database handling and scientific presentations and publications.
  5. The successful candidate will be available for a Zoom interview.
  6. An active ESR membership is required.

Duration of fellowship and funding

The training will start from autumn 2023 onwards and will last for twelve months. The selected fellow will receive a grant in the amount of $51,900/year directly paid out by MSK.

Programme structure

The programme offers an intensive, individualised instruction in nuclear medicine, nuclear cardiology, molecular imaging, theranostics, and clinical research methodology. While the programme will not include any patient contact, it includes training in nuclear medicine for diagnosis and intervention, incorporating daily image interpretation of PET-CT, and PET-MRI.

The programme will focus on participation in a theranostic clinical research study. In addition, individuals will collaborate on preparing an original research manuscript for publication and are mentored in grantsmanship to support research upon their return home.


After completion of the training programme, the fellow will receive a certificate from ESR/ESOR. In order to receive this, the fellow will be asked to present a written report about his/her work and activities during the programme.